These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 25414381)
1. Amyloid-beta and depression in healthy older adults: a systematic review. Harrington KD; Lim YY; Gould E; Maruff P Aust N Z J Psychiatry; 2015 Jan; 49(1):36-46. PubMed ID: 25414381 [TBL] [Abstract][Full Text] [Related]
7. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease. Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW; J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335 [TBL] [Abstract][Full Text] [Related]
8. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. Babulal GM; Ghoshal N; Head D; Vernon EK; Holtzman DM; Benzinger TLS; Fagan AM; Morris JC; Roe CM Am J Geriatr Psychiatry; 2016 Nov; 24(11):1095-1104. PubMed ID: 27426238 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity. Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072 [TBL] [Abstract][Full Text] [Related]
10. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting. Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006 [TBL] [Abstract][Full Text] [Related]
11. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Ben Bouallègue F; Mariano-Goulart D; Payoux P; Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967 [TBL] [Abstract][Full Text] [Related]
13. Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease. McDonough IM; Bischof GN; Kennedy KM; Rodrigue KM; Farrell ME; Park DC Neurobiol Aging; 2016 Oct; 46():68-75. PubMed ID: 27460151 [TBL] [Abstract][Full Text] [Related]
14. Different Sides of Depression in the Elderly: An In-depth View on the Role of Aβ Peptides. Pagni G; Tagliarini C; Carbone MG; Imbimbo BP; Marazziti D; Pomara N Curr Med Chem; 2022; 29(36):5731-5757. PubMed ID: 34547994 [TBL] [Abstract][Full Text] [Related]
15. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease. Villemagne VL; Rowe CC J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919 [TBL] [Abstract][Full Text] [Related]
16. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI. Harrington KD; Lim YY; Ellis KA; Copolov C; Darby D; Weinborn M; Ames D; Martins RN; Savage G; Szoeke C; Rowe C; Villemagne VL; Masters CL; Maruff P Int Psychogeriatr; 2013 Oct; 25(10):1667-77. PubMed ID: 23866942 [TBL] [Abstract][Full Text] [Related]
17. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease. Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767 [TBL] [Abstract][Full Text] [Related]